ResourceLife Sciences
Fecal calprotectin in patients with suspected colorectal cancer: A diagnostic accuracy study
30 Nov 2022In this article, Alpha Laboratories describes a study that was undertaken to determine the diagnostic accuracy of fecal calprotectin in patients referred with suspected colorectal cancer, both for clinically significant colorectal neoplasia and for all organic enteric disease.
Related Products
Request Quote for All Products
Calprotectin ELISA
Alpha Laboratories LtdThe BÜHLMANN fCAL® ELISA (EK-CAL) is the UK market-leading calprotectin ELISA. It provides quantitative in vitro determination of fecal calprotectin in high sample throughput environments.